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Abstract Although a requirement of zinc (Zn) for normal
brain development is well documented, the extent to which
Zn can modulate neuronal proliferation and apoptosis is not
clear. Thus, we investigated the role of Zn in the regulation
of these two critical events. A low Zn availability leads to
decreased cell viability in human neuroblastoma IMR-32
cells and primary cultures of rat cortical neurons. This
occurs in part as a consequence of decreased cell prolif-
eration and increased apoptotic cell death. In IMR-32 cells,
Zn deficiency led to the inhibition of cell proliferation
through the arrest of the cell cycle at the G0/G1 phase. Zn
deficiency induced apoptosis in both proliferating and
quiescent neuronal cells via the intrinsic apoptotic path-
way. Reductions in cellular Zn triggered a translocation of
the pro-apoptotic protein Bad to the mitochondria, cyto-
chrome c release, and caspase-3 activation. Apoptosis is
the resultant of the inhibition of the prosurvival extra-
cellular-signal-regulated kinase, the inhibition of nuclear
factor-kappa B, and associated decreased expression of
antiapoptotic proteins, and to a direct activation of caspase-
3. A deficit of Zn during critical developmental periods can
have persistent effects on brain function secondary to a
deregulation of neuronal proliferation and apoptosis.
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Abbreviations
Cdks Cyclin-dependent kinases
DTPA Diethylenetriamine pentaacetic acid
EMSA Electrophoretic mobility shift assay
ERK Extracellular-signal-regulated kinase
FBS Fetal bovine serum
MAPK Mitogen-activated kinases
NF-jB Nuclear factor-kappa B
Zn Zinc
Introduction
Zinc (Zn) is an essential nutrient that has multiple roles in
the nervous system (Frederickson et al. 2005); deficits of
this nutrient can result in numerous diverse pathologies
(Rogers et al. 1990; Keen et al. 1995; Sandstead 2003). Zn
exists largely bound to proteins, and numerous enzymes
require Zn including DNA and RNA polymerases, several
enzymes in the intermediary metabolism, and most
metalloproteinases. Zn is also a structural component of a
family of Zn-binding proteins known as Zn-finger proteins
that act as DNA-binding transcription factors. While protein
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bound Zn is important, large amounts of Zn are not protein
bound. For example, about 10% of Zn in the nervous system
is associated with pre-synaptic vesicles of glutaminergic
neurons; this Zn, which is not protein bound, is released as
free Zn into the synaptic cleft where it can modulate the
activity of a variety of post-synaptic receptors (Frederickson
et al. 2005).
In rodent models, severe Zn deficiency throughout
pregnancy can result in multiple brain malformations
(Hurley and Swenerton 1966), and deficits of this nutrient
during the early postnatal period can affect the number and
differentiation of neurons in the cerebellum (Dvergsten
et al. 1983, 1984a, b). Mild Zn deficiency can result in
alterations in learning, attention, and memory in rodents and
non-human primates (reviewed in Golub et al. 1995, 2000).
In humans, maternal dietary Zn intakes during pregnancy
have been reported to be inversely associated with the head
circumference of the infant at birth (Lagiou et al. 2005), and
Zn supplementation has been associated with larger head
circumferences in infants from women with low body mass
index (Goldenberg et al. 1995). There is a growing body of
evidence that supports the concept that in humans, subop-
timal Zn nutrition during development is associated with
altered neonatal/infant behavior, cognitive, and motor per-
formance (Kirksey et al. 1994; Bentley et al. 1997; Penland
et al. 1997; Gardner et al. 2005).
Zn plays an essential role in cell proliferation
(MacDonald et al. 1998; Wang et al. 2002; Wong et al.
2007; Corniola et al. 2008) and apoptosis (reviewed in
Truong-Tran et al. 2003; Clegg et al. 2005; Fraker 2005;
Corniola et al. 2008) in different tissues and cell types. The
regulation of cell proliferation by Zn can occur at different
levels including the requirement of Zn for the activity of
enzymes involved in DNA synthesis (i.e., deoxythymidine
kinase), and the modulation of regulatory signals directly,
as well as indirectly, through its effects on the hormonal
regulation of cell division. Illustrative of this, the pituitary
growth hormone-insulin-like growth factor-1 axis is
responsive to Zn status (MacDonald 2000), although its
role in Zn deficiency-associated decreases in cell prolifer-
ation is an issue of controversy (Ninh et al. 1998; Wang
et al. 2002). Low cellular Zn concentrations can trigger
apoptosis in numerous cell types, including fibroblasts,
hepatocytes, T-cell precursors, glioma, and testicular cells.
The mechanisms involved in the induction of apoptosis
secondary to Zn deficiency are multiple, and differ among
different cell types. Zn can act as an inhibitor of caspase-3,
a cysteine protease that is central in apoptosis cleaving key
proteins [e.g., poly(ADPribose) polymerase (PARP)] that
continue the apoptotic cascade (reviewed in Truong-Tran
et al. 2001). Zn deficiency can also induce apoptosis by
disrupting growth factors signal transduction pathways
mediated by receptor tyrosine kinases (Clegg et al. 2005).
While somewhat controversial (Zago et al. 2005), it has
also been proposed that an increase in cell oxidants triggers
apoptosis (Clegg et al. 2005).
Studies with experimental animals, as well as in cell
models, have shown that neurons can be particularly
affected by a low availability of Zn. In rats, postnatal Zn
deficiency impaired the normal development of the cere-
bellum, affecting the number and differentiation of Pur-
kinje, basket, stellate, and granule cells (Sandstead 2003).
In human neuroblastoma IMR-32 cells, we observed that
with Zn deficiency there is a reduction in cell viability,
with evidence of increased apoptotic death (Verstraeten
et al. 2004; Zago et al. 2005).
In the nervous system, cell proliferation and apoptosis
actively occur during the perinatal period, and are critical
for normal neurodevelopment. Alterations in these tightly
regulated events can affect the function of the nervous
system latter in life. Given the close interrelationships
between cell proliferation and death in the development of
the nervous system, and to better understand the role of Zn
in this process, in this study we investigated if a low Zn
availability can affect neuronal proliferation and survival.
As experimental models, we investigated the effects of Zn
deficiency on neuronal proliferation in human neuroblas-
toma cells (IMR-32), and on apoptosis in IMR-32 cells,
and primary cultures of differentiated rat cortical neurons.
We show that with a deficit of Zn, there is an inhibition of
neuronal cell proliferation that is secondary to an arrest at
the G0/G1 phase of the cell cycle. Interestingly, in prolif-
erating as well as in quiescent neurons, Zn deficiency
triggers apoptotic neuronal death. The apoptosis occurs via
the intrinsic pathway which can be a consequence of
extracellular-signal-regulated kinase (ERK) inhibition,
caspase-3 activation, and the down-regulation of nuclear
factor-kappa B (NF-jB)-dependent anti-apoptotic genes.
Materials and Methods
Materials
The IMR-32 neuroblastoma cells were obtained from the
American Type Culture Collection (Rockville, MA, USA).
Cell culture media and reagents were purchased from
Invitrogen Life Technologies (Carlbad, CA, USA). The
CellTiter-Glo Luminescent Cell Viability Assay, the oli-
gonucleotides containing the consensus sequence for
NF-jB (50-AGTTGAGGGGACTTTCCCAGGC-30) and
OCT-1, and the reagents for the electrophoretic mobility
shift assay (EMSA) assay were obtained from Promega
(Madison, WI, USA). Polyclonal antibodies for Akt,
phosphorylated Akt (Ser 473), Bcl-2, c-myc, c-IAP1, and
XIAP, and phosphorylated Bad (Ser 112 or Ser 136) were
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obtained from Cell Signaling Technology (Beverly, MA,
USA). Antibodies for p53, ERK1/2, phosphorylated ERK,
p21, cyclin D1 and E, PARP, Bad, cytochrome c, Bcl-xL,
and b-tubulin were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Polyvinylidene difluoride (PVDF)
membranes were obtained from BIO-RAD (Hercules, CA,
USA). Merocyanine 540 and propidium iodide were
obtained from Molecular Probes (Eugene, OR, USA). The
ECL Plus western blotting detection reagents were from
GE Healthcare (Piscataway, NJ, USA). The APO-BrdUTM
kit and BD CycletestTM Plus DNA reagent kit were
obtained from Pharmingen-Becton-Dickinson Co. (San
Diego, CA, USA). The ApoAlert-Caspase-3 Assay was
purchased from Clontech (Mount View, CA, USA). All
other reagents were from the highest quality available and
were purchased from Sigma (St. Louis, MO, USA).
Cell Cultures and Incubation
Zn-deficient fetal bovine serum (FBS) was prepared by
chelation with diethylenetriamine pentaacetic acid (DTPA)
as previously described (Oteiza et al. 2000; Mackenzie
et al. 2002b). The chelated FBS was subsequently diluted
with complex medium or DMEM to a final concentration
of 3 mg protein/ml to match the protein concentration of
the control non-chelated medium [10% (v/v) FBS]. The
concentration of Zn in the deficient medium was 1.5 lM.
Aliquots of the Zn-deficient media were supplemented with
ZnSO4 to a final Zn concentration of 15 lM.
IMR-32 cells were cultured at 37C in complex medium
[55% (v/v) DMEM high glucose, 30% (v/v) Ham F-12,
5% (v/v) a-MEM] supplemented with 10% (v/v) FBS and
antibiotics-antimycotic (50 U/ml penicillin, 50 lg/ml
streptomycin, and 0.125 lg/ml amphotericin B). Cells
were grown in control medium [complex medium con-
taining 10% (v/v) non-chelated FBS] until 90% confluence.
Depending on the experimental conditions, synchronized
or unsynchronized IMR-32 cells were incubated in control
non-chelated medium or in chelated media containing 1.5
or 15 lM Zn. Cells were harvested at different time points
(6–48 h) depending on each experiment. We previously
reported that the incubation of IMR-32 cells in media
containing low Zn concentrations (1.5 and 5 lM Zn)
results in a reduction of cellular labile Zn pools within 3 h
(Mackenzie et al. 2002a).
For the isolation of cortical neurons, timed-pregnant
Sprague–Dawley rats were obtained from Charles Rivers
Laboratories (Wilmington, MA, USA). All animal proce-
dures were in agreement with standards for the care of
laboratory animals as outlined in the NIH Guide for the
Care and Use of Laboratory Animals. Primary cortical
cultures were prepared from E19 embryos according to
Banker and Goslin (1998). In brief, embryos were rapidly
removed under sterile conditions, and after removal of the
skull and meninges, the cerebral hemispheres were dis-
sected out and placed in Hanks’ balanced salt solution
prewarmed to 37C. Cortical tissue was dissociated by
enzymatic digestion (0.025% w/v trypsin). Trypsinization
was stopped by the addition of Hanks’ solution containing
20% (v/v) FBS, and the tissue was mechanically dissociated
in Hanks’ balanced salt solution containing 0.004% (w/v)
DNAse with Pasteur pipettes of different diameters. The
resulting cell suspension was centrifuged at 2009g for
5 min. The cells were resuspended in a known volume of
Neurobasal culture medium supplemented with 2% (v/v)
serum-free additive B27, and plated on poly-L-lysine-coated
dishes. Cell cultures were incubated at 37C in an atmo-
sphere of 95% (v/v) air, 5% (v/v) CO2 with 90–95% (v/v)
humidity. After 24 h in culture, the media were replaced by
DMEM high glucose supplemented with 10% (v/v) FBS.
After 72 h, cell cultures were supplemented with 40 lM
cytosine-b-D-arabinoside for 24 h to inhibit non-neuronal
cell proliferation. After 7–9 days in culture, the media were
replaced by control non-chelated medium, or chelated
medium containing 1.5 or 15 lM Zn, and cells were further
incubated for 6–24 h depending on the experiment.
Cell viability for IMR-32 and cortical neurons was
measured evaluating the cell ATP content (CellTiter-Glo
Luminescent Cell Viability) according to manufacturer’s
protocol.
Evaluation of Cell Cycle Progression
For synchronization, IMR-32 cells were serum-starved for
48 h in complex medium containing 0.1% (v/v) FBS.
Re-entry into G1 phase of the cell cycle was initiated by
replacement of the starvation medium with complete or
chelated media containing 1.5 or 15 lM Zn. After 0, 12,
16, and 24 h, cells were collected, washed and the analysis
of nuclear DNA was performed using the CycletestTM Plus
DNA Reagent Kit. Propidium iodide-stained nuclei were
analyzed by flow cytometry on a Becton-Dickinson
cytometer and the percentage of cells in the G0–G1, S, and
G2–M phases of the cell cycle were determined by using
the Mod Fit LT cell cycle analysis software (Verity Soft-
ware, Topsham, ME, USA).
Western Blot
Cells were washed in PBS and whole cell extracts were
prepared by lysis in 50 mM Hepes buffer (pH 7.4), con-
taining 150 mM NaCl, 0.5 mM EDTA, 2% (v/v) Igepal,
phosphatase inhibitors (1 mM sodium pervanadate, 100 lM
NaF), and protease inhibitors (1 mM PMSF, 5 lg/ml leu-
peptin, 1 mg/l pepstatin, and 10 lg/ml aprotinin). Lysates
were exposed to one cycle of freezing and thawing,
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incubated for 30 min on ice and centrifuged at 150009g for
30 min. Nuclear fractions were isolated as previously
described (Mackenzie et al. 2002b). The protein content in
the samples was measured according to Bradford (1976).
Aliquots of total or nuclear fractions containing
25–50 lg of protein were separated by SDS-PAGE
[10–12.5% (w/v) acrylamide] (Laemmli 1970) blotted onto
PVDF membranes and subsequently probed with the dif-
ferent primary antibodies followed by a secondary horse-
radish peroxidase-conjugated antibody. The bands were
visualized by enhanced chemiluminescence (ECL plus,
Amersham Biosciences, Piscataway, NJ, USA) and mea-
sured using a Phosphoimager 840 (GE Healthcare).
Electrophoretic Mobility Shift Assay
Nuclear fractions were isolated as previously described
(Mackenzie et al. 2006a). For the EMSA, the oligonucle-
otides containing the consensus sequences for NF-jB or
OCT-1 were end labeled with [c-32P] ATP using T4
polynucleotide kinase and purified using Chroma Spin-10
columns. Samples were incubated with the corresponding
labeled oligonucleotide (20000–30000 cpm) for 20 min at
room temperature in 19 binding buffer [59: 50 mM Tris–
HCl buffer, pH 7.5, containing 20% (v/v) glycerol, 5 mM
MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250 mM NaCl, and
0.25 mg/ml poly(dI-dC)]. The products were separated by
electrophoresis in a 6% (w/v) non-denaturing polyacryl-
amide gel using 0.59 TBE (45 mM Tris/borate, 1 mM
EDTA) as the running buffer. The gels were dried and
radioactivity was measured using a Phosphoimager 840.
Evaluation of Apoptosis
Assay of Caspase-3 Activity
Caspase-3 activity was determined in cell lysates after
incubating IMR-32 cells for 12, 24, 36, and 48 h, and
cortical neurons for 12, 18, and 24 h, in control or chelated
media containing 1.5 or 15 lM Zn. Caspase-3 activity was
measured using the ApoAlert-Caspase-3 Assay following
manufacturer’s protocol.
Caspase-3 activity was also determined measuring the
proteolytic processing of full-length PARP [poly(ADPri-
bose) polymerase] by Western blot analysis as described
above.
TUNEL Assay
Apoptotic nuclei were identified in IMR-32 and cortical
neurons after 48 and 24 h of incubation, respectively, in
control or chelated media containing 1.5 or 15 lM Zn by
evaluating DNA breaks with the TUNEL assay, either by
confocal fluorescence microscopy (laser scanning confocal
microscope Nikon D-ECLIPSE C1si) or by flow cytometry.
For analysis by flow cytometry, control and treated cells
were collected in their culture medium, pelleted by cen-
trifugation at 3009g for 5 min and rinsed with PBS. Cells
were fixed with 1% (w/v) paraformaldehyde in PBS and
after 15 min on ice, washed, and resuspended in PBS.
Seventy percent (v/v) cold ethanol was added to the sus-
pension and placed overnight at -20C. After centrifuga-
tion, the cells were washed and resuspended in 50 ll of the
staining solution containing the terminal deoxynucleotidyl
transferase enzyme and FITC-dUTP and incubated for 2 h
at 37C. At the end of the incubation time, the cells were
washed, resuspended in 0.5 ml of the propidium iodide/
RNAse solution, and analyzed on a Becton-Dickinson flow
cytometer.
Translocation of Phosphatidyl Serine to the Outer Layer
of the Plasma Membrane
The translocation of phosphatidyl serine was evaluated
measuring the cell binding of merocyanine (Verstraeten et al.
2004). IMR-32 (1 9 104 cells) cells suspended in 0.3 ml of
50 mM Hepes buffer (pH 7.4) containing 125 mM KCl were
added with 10 lM merocyanine, and incubated at room
temperature for 10 min in the darkness. Merocyanine bind-
ing to phosphatidylserine was evaluated as the increase in the
fluorescence emission at 578 nm (kexcitation, 555 nm)
using an SFM-25 Kontron fluorometer (Kontron Instruments
s.p.A, Milan, Italy). To evaluate DNA content, cells were
disrupted by a 30-min incubation in presence of 0.1% (v/v)
Igepal, and incubated for further 20 min with 50 lM pro-
pidium iodide. The fluorescence at 590 nm (kexcitation,
538 nm) was measured, and results are expressed as the
merocyanine/propidium iodide fluorescence ratio.
Cytochrome c Release
To characterize the release of cytochrome c, 18 h after
incubating IMR-32 cells in the presence of control or
chelated media containing 1.5 or 15 lM Zn, cells were
harvested in their culture medium, pelleted by centrifuga-
tion at 3009g for 5 min, rinsed with PBS, and resuspended
in 250 ll of 20 mM Hepes buffer (pH 7.5) containing
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
1 mM dithiothreitol, 250 mM sucrose, and a mixture of
protease inhibitors. Cells were homogenized with a glass
Pyrex homogenizer and centrifuged at 10009g for 10 min
to remove nuclei and unbroken cells. The resulting super-
nate was subjected to a 100009g centrifugation for 20 min
at 4C and the pellet, corresponding to the mitochondrial
fraction, was solubilized in 50 ll of 10 mM Tris buffer
(pH 8), 0.05% (v/v) Igepal, and 5 mM CaCl2. The resulting
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supernate was centrifuged at 1000009g for 1 h at 4C to
obtain the cytosolic fraction. Cytochrome c and Bad con-
tent in mitochondrial and cytosolic fractions were mea-
sured by Western blot analysis as described above.
Statistical Analysis
One-way analysis of variance (ANOVA) with subsequent
post-hoc comparisons by Scheffe were performed
using Statview 5.0 (SAS Institute, Cary, NC, USA). A
P-value \0.05 was considered statistically significant.
Values are given as means ± SEM.
Results
A Decrease in Zn Availability Decreases IMR-32
Neuroblastoma Cell Viability
To investigate the requirement of Zn for neuronal prolif-
eration, the human neuroblastoma cell line IMR-32 was
used as a model. These cells can be differentiated in vitro
to a phenotype of cortical neurons, thus they can comple-
ment observations made using primary cortical neurons.
The effects of low extracellular Zn concentrations on
IMR-32 cell viability were initially investigated (Fig. 1).
IMR-32 cells were incubated for 12–48 h in control med-
ium or in chelated medium containing 1.5 or 15 lM Zn,
and cell viability was evaluated measuring the intracellular
content of ATP. Cell viability was similar among the
groups after 12 h of incubation, but at 24 and 48 h, cell
viability was significantly lower (P \ 0.05) for the cells
incubated in the Zn deficient (1.5 lM Zn) media compared
to controls (15 and 35%, respectively). The finding that cell
viability was similar for the groups incubated in chelated
medium supplemented with 15 lM Zn and in control
medium at all the time points investigated, suggesting that
the low cell viability found in the 1.5 Zn group can be
attributed to the decrease in Zn availability. Under similar
experimental conditions, we previously described that the
incubation of cells in media containing 1.5 lM Zn leads to
a rapid decrease in, labile, as well as total, Zn concentra-
tions (Mackenzie et al. 2002a, 2006a).
A Decrease in Zn Availability Inhibits IMR-32
Neuroblastoma Cell Proliferation
The observed decrease in IMR-32 cell viability in cells
exposed to medium containing 1.5 lM Zn could have
occurred secondary to a requirement of Zn for cell prolif-
eration and/or to the occurrence of apoptotic cell death. To
investigate this, the progression of the cell cycle was
investigated. Cell cycle in IMR-32 cells occurs within
24 h, and the entry into the S phase occurs between 12 and
16 h (30 and 35% of cells in S phase, respectively) (data
not shown). The effects of varying extracellular Zn con-
centrations on the distribution of cells in S, G0–G1, and
G2–M phases were characterized after 0, 9, 12, 16, and
24 h, respectively. At time 0, in synchronized cells,
approximately 75% of the cells were in G0–G1 phase of the
cell cycle. At 12 h, there were no significant differences in
the proportion of cells in G1, S, and G2–M phases among
the groups. At 16 h (Fig. 2a), cells incubated in the 1.5 lM
Zn media exhibited a significant (P \ 0.05) growth arrest
in G1 phase (74 ± 1, 61 ± 1, and 59 ± 2% cells in G0–G1
phase for the 1.5, 15 lM Zn, and control cells, respec-
tively) (Fig. 2a).
Key proteins involved in the control of the G1/S check-
point of the cell cycle were subsequently investigated. In
synchronized IMR-32 cells, the incubation in control
medium for 9 h was associated with a marked reduction in
p21; a protein that inhibits G1–S transition, p21 levels
remained low for the subsequent 15 h. In the cells incubated
in medium containing 1.5 lM Zn, p21 levels remained
relatively high throughout the 24 h culture period. Consis-
tent with the above, the levels of p53, a protein that posi-
tively regulates p21, were higher in IMR-32 cells incubated
in 1.5 lM Zn medium compared to controls at all time
points (6–24 h). In concordance with the arrest of the cell
cycle in G1 phase, Zn deficiency resulted in a reduction in
cyclin D1 and E protein levels after 6 h of incubation, the
levels remained low throughout the 24 h study period
(Fig. 2b). The mitogen-activated kinase (MAPK) ERK has
an important role in the regulation of cell proliferation. The
incubation of IMR-32 cells in 1.5 lM Zn medium was
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Fig. 1 The influence of Zn deficiency on IMR-32 cell viability. IMR-
32 cells were incubated for 1–48 h in control non-chelated medium
(C) or chelated media containing 1.5 or 15 lM Zn, after which cell
viability was measured as described in ‘‘Materials and methods’’
section. Results are shown as means ± SEM of four independent
experiments. * Significantly different compared to C and 15 lM Zn
groups (P \ 0.01, one-way ANOVA test)
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associated with a marked decrease in ERK phosphorylation
that occurred throughout the 24 h period (Fig. 2b).
A Decrease in Zn Availability Induces Apoptotic Death
in IMR-32 Neuroblastoma Cells and Primary Cortical
Neurons
The involvement of apoptotic cell death in the decreased
cell viability associated with Zn deficiency was assessed by
evaluating different steps in the apoptotic cascade, the
activation of the effector caspase-3 (caspase-3 activity and
degradation of its substrate, PARP), DNA fragmentation,
and the translocation of phosphatidyl serine to the outer
cell membrane leaflet.
For IMR-32 cells, their incubation in low Zn medium
led to a time-dependent activation of caspase-3 (Fig. 3a, b).
The increased activation of caspase-3, measured as enzyme
activity, was significant after incubating the cells for 24 h
in the 1.5 lM Zn medium compared to the control cells.
Caspase-3 activity remained elevated for the subsequent
24 h (threefold higher than in controls) (Fig. 3a). When
cells were simultaneously incubated for 24 h in 1.5 lM Zn
medium supplemented with the antioxidant a-lipoic acid
(0.5 mM), the activity of caspase-3 remained high
(100 ± 8, 176 ± 6, and 184 ± 20, for cells incubated in
the following media: control, 1.5 lM Zn, and 1.5 lM Zn
added with a-lipoic acid, respectively). The activation of
caspase-3 in the 1.5 lM Zn group was also observed when
Control 1.5 µM Zn
G0-G1 G1.95: 0-G1 G7.37: 0-G1 :60.7
15 µM Zn
a
S: 34.9
G2-M: 2.1
S: 26.6
G2-M: 0.2
S: 34.5
G2-M: 0.9
p53 >
C      1.5       C     1.5       C     1.5       C      1.5
6 h               9 h             12 h             24 h        b
Ratio p53/β-tubulin:  0.46     0.89      0.58     0.97    0.62     1.17     0.32     0.72        
p21 >
Cyclin D1 >
Cyclin E   >
Ratio p21/β-tubulin: 0.78     0.80     0.18      0.57     0.17      0.59    0.19      0.61
Ratio Cyclin D1/β-tubulin:  0.30     0.24     0.18     0.09      0.23      0.11    0.22     0.10
β-tubulin  >
p-ERK 1/2 >
ERK 1/2 >
Ratio Cyclin E/β-tubulin:
:
0.11      0.07      0.14     0.10      0.31    0.23    0.43    0.17
Ratio p-ERK/ERK 1.02 0.23 0.94 0.18 0.94 0.32 0.99 0.20
Fig. 2 Zn deficiency affects the distribution of events in the IMR-32
cell cycle. a Synchronized IMR-32 cells were incubated for 16 h in
control non-chelated medium (C) or chelated media containing 1.5 or
15 lM Zn. The evaluation of cell cycle progression was done as
described in ‘‘Materials and methods’’ section. The histograms show
DNA staining by propidium iodide. The figure shows representative
FACS profiles of the distribution of cells in G0–G1, S, and G2–M
phases from four independent experiments. b Western blot for p53,
cyclins E and D1, p-ERK, ERK, and tubulin in total cell fractions, and
p21 (nuclear fractions), in synchronized cells incubated in control (C)
or the media containing 1.5 lM Zn (1.5) for the indicated period of
time. The figure shows representative images. Numbers under the
figures are means from three independent experiments. Values for the
1.5 Zn group are significantly different (P \ 0.05) compared to
controls at all the times measured for p53, cyclins D1 and E, and
p-ERK, and between 9 and 24 h for p21
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Fig. 3 Zn deficiency induces apoptotic cell death in IMR-32 cells.
Cells were incubated in control non-chelated medium (C) or chelated
media containing 1.5 (1.5 Zn) or 15 lM (15 Zn) Zn for the different
periods of time. a Caspase-3 activity after 12, 24, 36, and 48 h of
incubation, in the different experimental conditions. b Western blot
for full-length and cleaved-PARP in IMR-32 cells incubated in the
corresponding media. One representative image out of three inde-
pendent experiments is shown. c Western blots for Bad and
cytochrome c (cyt c) in cytosolic or mitochondrial fractions after
18 h incubation. Representative images out of two to three indepen-
dent experiments are shown. d DNA nicks were evaluated with the
TUNEL staining after 48 h incubation, and the percentage of
apoptotic cells was calculated. Results are shown as means ± SEM
of four independent experiments. e After 18, 48, and 72 h incubation
in the corresponding media, the amount of phosphatidylserine in the
outer layer of the cell membrane was evaluated fluorometrically
measuring merocyanine 540 (MC) binding, and is expressed relative
to the amount of DNA measured as propidium iodide (PI) fluores-
cence. All results are shown as means ± SEM of two to four
independent experiments. * Significantly different compared to C and
15 lM Zn groups (P \ 0.01, one-way ANOVA test)
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the cleavage of PARP, from the full-length protein
(116 kDa) to the cleaved form (85 kDa), was assessed by
Western blot (Fig. 3b). In the control and the 15 lM Zn
groups, caspase-3 activity was stable over the culture
period; values were similar in the two groups (Fig. 3a, b).
The key event in the intrinsic apoptotic pathway is the
release of cytochrome c, a component of the mitochondrial
respiratory chain, to the cytosol where it activates Apaf-1
leading to the subsequent activation of caspase-9 and cas-
pase-3. In support of the activation of this pathway in Zn
deficiency, cytochrome c levels were high in the cytosol of
IMR-32 cells incubated in 1.5 lM Zn medium for 18 h
(Fig. 3c). Accordingly, the mitochondrial content of the
pro-apoptotic protein Bad, involved in the mitochondrial
release of cytochrome c, was high in mitochondrial frac-
tions, isolated from the Zn-deficient cells (Fig. 3c). Evalu-
ation of DNA fragmentation, as assessed by TUNEL
staining of DNA nicks and subsequent quantitation by cell
cytometry, showed 45% of apoptotic cells after 48 h incu-
bation in the 1.5 lM Zn medium (Fig. 3d). The increase in
phosphatidylserine translocation was statistically signifi-
cant after 48 and 72 h incubation in the 1.5 lM Zn medium,
compared to cells incubated in control and 15 lM Zn media
(Fig. 3e). DNA fragmentation and phosphatidyl serine
externalization levels were similar for the control and
15 lM Zn groups (Fig. 3d, e). Similar to the observations
with the IMR-32 cells, a decrease in the availability of Zn
induced apoptotic cell death in primary cultures of rat
cortical neurons (Fig. 4a). Cortical neurons incubated in
1.5 lM Zn medium were characterized by low cell viability
after 24 h incubation that was prevented by supplementing
the chelated medium with 15 lM Zn. Zn deficiency induced
apoptotic cell death in rat cortical neurons, as evidenced by
the activation of caspase-3 after 18 h incubation (Fig. 4b);
and by high levels of DNA fragmentation after 24 h, as
evaluated by confocal microscopy (Fig. 4c). The simulta-
neous incubation with 0.5 mM a-lipoic acid did not prevent
the activation of caspase-3 that occurs when neuronal Zn
decreases (Fig. 4b).
Neuronal Signaling Pathways Involved in the
Triggering of Apoptosis When the Availability
of Zn Decreases
The kinases ERK and Akt participate in the inhibition of the
intrinsic apoptotic pathway, by phosphorylating Bad, which
prevents its translocation to the mitochondria. We next
investigated if the ERK/Akt/Bad pathways were involved in
the induction of apoptosis when neuronal Zn decreases.
After incubating IMR-32 and cortical neurons in Zn-defi-
cient medium for 9 h, phosphorylated ERK1/2 levels were
low, compared to levels in cells incubated in control or
15 lM Zn media (Fig. 5a). At the same time, the levels of
phosphorylated Akt were high in cortical neurons and IMR-
32 cells incubated in the Zn-deficient medium compared to
levels in controls (Fig. 5a). While Akt promotes cell sur-
vival through its ability to phosphorylate Bad at Ser136,
ERK phosphorylates Bad at Ser112. In IMR-32 cells and rat
cortical neurons incubated for 9 h in 1.5 lM Zn medium,
the levels of Bad phosphorylated at Ser136 were high,
whereas those of Bad phosphorylated at Ser112 were sim-
ilar to those observed in control cells (Fig. 5b). These
results suggest that Akt activation in the Zn-deficient cells
cannot counteract the pro-apoptotic consequences of ERK
inhibition.
We previously demonstrated that Zn deficiency can
decrease the nuclear translocation of transcription factor
NF-jB into the nucleus, inhibiting the NF-jB-regulated
expression of select genes (Mackenzie et al. 2002b). As
expected, NF-jB-DNA binding was lower in nuclear
fractions from IMR-32 and rat cortical neurons incubated
in 1.5 lM Zn medium for 36 and 24 h, respectively,
compared to controls (Fig. 6a). Several proteins (c-IAP-1,
XIAP, Bcl-xL, and Bcl-2) involved in the protection of
cells from apoptosis are regulated by NF-jB. c-IAP1 acts
inhibiting caspases, XIAP exerts its anti-apoptotic action
through the interaction with several partners (caspase-3,
caspase-9, DIABLO/Smac) and Bcl-xL and Bcl-2 inhibit
apoptosis by preventing the opening of the mitochondrial
pore. Thus, we next investigated the effects of varying
extracellular Zn concentrations on the expression of
NF-jB-regulated anti-apoptotic proteins. In IMR-32 and
rat cortical neurons incubated in Zn-deficient medium for
36 and 24 h, respectively, a decreased content of c-IAP1,
XIAP, Bcl-xL, and Bcl-2 was observed in cortical neurons
and of XIAP and Bcl-2 in IMR-32 cells (Fig. 6b). These
findings support a role of NF-jB inhibition in the trigger-
ing of apoptosis when neuronal Zn availability decreases.
Discussion
In this study, we demonstrate Zn modulates neuronal pro-
liferation and survival. A deficit of Zn can result in an
inhibition of neuronal cell proliferation secondary to an
arrest at the G0/G1 phase of the cell cycle. In proliferating
as well as in quiescent neurons, Zn deficiency can trigger
apoptotic neuronal death. Apoptosis occurs through the
intrinsic pathway which can be a consequence of ERK
inhibition, caspase-3 activation, and the down-regulation of
NF-jB-dependent anti-apoptotic genes.
Under the conditions employed in this study, Zn defi-
ciency caused an arrest in IMR-32 cell cycle progression at
the G0/G1 phase. A similar finding was observed in HepG2
human hepatoblastoma cells (Wong et al. 2007). Accord-
ingly, male rats fed a Zn-deficient diet have a decreased
8 Neurotox Res (2010) 17:1–14
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number of proliferating stem cells in the subgranular zone
and granular cell layer of the dentate gyrus compared to
controls (Corniola et al. 2008). A key aspect in the cell
cycle regulation is the MAPK pathway, Raf/MEK/ERK1/2
that can be activated by mitogenic signals, cytokines, and
growth factors (Steelman et al. 2004). The ERK signaling
pathway is involved in the integration of environmental
signals (nutrients, mitogens, and cytostatic factors) that
lead to DNA replication during the S phase, and in relaying
the information to the cell cycle control system. ERK
activation throughout G1 is required for the cell entry into S
phase (Yamamoto et al. 2006). Zn deficiency caused a
rapid inhibition of ERK1/2 phosphorylation in IMR-32
cells supporting a role of this pathway in the associated cell
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Fig. 4 Zn deficiency induces apoptotic cell death in rat cortical
neurons. Rat cortical neurons were incubated for 12, 18, or 24 h in
control non-chelated medium (C) or chelated media containing 1.5
(1.5 Zn) or 15 lM (15 Zn) Zn. a Cell viability was measured as
described in ‘‘Materials and methods’’ section. Results are shown as
means ± SEM of four independent experiments. * Significantly
different compared to C and 15 lM Zn groups (P \ 0.01, one-way
ANOVA test). b (Left panel) Caspase-3 activity was measured after
18 h incubation in control non-chelated medium (C) or chelated
medium containing 1.5 lM Zn without (1.5 Zn) or with the addition
of 0.5 mM a-lipoic acid. (Right panel) Western blot for full-length
and cleaved-PARP in total cell extracts isolated from rat cortical
neurons incubated for 18 h in the corresponding media. Results are
shown as means ± SEM (Fig. 3a, b left panel) or means (Fig. 3b
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24 h in the corresponding media. Fluo fluorescein, PI propidium
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cycle arrest. Accordingly, the ERK inhibitor (PD 98059)
causes a significant decrease in IMR-32 cell viability
within 24 h (Zago et al. 2005), supporting a role of ERK in
IMR-32 cell proliferation. A down-regulation of cyclins D
and E was also observed in Zn-deficient cells. Major
components of the regulation of G1 to phase S transition
are the cyclin-dependent kinases (Cdks) and their regula-
tory cyclins (Sherr 2000). During the G1 phase, cyclin D
assembles with its catalytic partners Cdk4 or Cdk6 which
in turn phosphorylate members of the retinoblastoma
family of proteins. Cyclin E-Cdk2 activates later in G1
phase. Because ERK upregulates cyclins D1 and E, the
findings of decreased cyclins D1 and E levels in the
Zn-deficient IMR-32 cells are consistent with the observed
ERK inhibition and Go/G1 arrest. Zn deficiency also
increased p53 protein levels which can occur as a conse-
quence of Zn deficiency-induced activation of the MAPK
(JNK/p-38)-AP-1 signaling pathway (Zago et al. 2005). As
previously proposed (Corniola et al. 2008), Zn deficiency-
induced p53 upregulation can underlie an increased
expression of downstream target genes which could con-
tribute to the triggering of cell cycle arrest (Cdk inhibitor
p21, and others) and apoptosis (Corniola et al. 2008;
Miyashita and Reed 1995; Miyashita et al. 1994).
Other molecular events may contribute to the decreased
cell proliferation in the Zn-deficient neuronal cells. It has
been proposed that the regulation of the cell cycle by Zn
could be secondary to its requirement for enzyme systems
that influence cell division and proliferation (Clegg et al.
1989; MacDonald 2000; Beyersmann and Haase 2001), and
to the impaired tubulin polymerization that is associated with
Zn deficiency (Oteiza et al. 1990). An altered neuronal
microtubule assembly (Mackenzie et al. 2002b) could impair
the formation of the mitotic spindle affecting mitosis.
Zn deficiency induced apoptotic cell death in IMR-32
cells and in cortical neurons as evidenced by caspase-3
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activation, phosphatidylserine externalization, and DNA
fragmentation. Apoptotic cell death is consistently associ-
ated with Zn deficiency in animal as well as cell models
(Fraker and Telford 1997; Jankowski-Hennig et al. 2000;
Duffy et al. 2001; Truong-Tran et al. 2001; Clegg et al.
2005; Fraker 2005; Corniola et al. 2008). Different
hypothesis have been reported for the induction of
apoptosis when cellular Zn decreases. These include the
action of Zn as a direct caspase regulator, alterations in
receptor tyrosine kinase signaling, mitochondrial dysfunc-
tion, and increased oxidative stress (Truong-Tran et al.
2001; Clegg et al. 2005).
We previously observed that the increase in cell oxi-
dants and the associated activation of JNK/p38/AP-1 is not
a
Zn (µM)
IMR-32 cells RCN
1.5 15C C 1.5 Zn
NF-κB >
1.2
*
0.0
0.4
0.8
*
C 1.5 15  C 1.5
IMR-32 RCN
N
F-
Κ
B
-D
N
A
 b
in
di
ng
(A
.U
)
IMR-32 cells RCN
C 1.5 ZnC 1.5 15
Zn (µM) 
c-IAP1  >
c-IAP1  >
b
Ratio c-IAP1/β-tubulin: 1.00            0.69*
Ratio c-IAP1/β-tubulin: 1.00  0.81 1.00
Bcl-xL >
B l 2
XIAP >
Bcl-xL >
XIAP  >
Ratio Bcl-xL/β-tubulin: 1.00          0.62*
Ratio XIAP/β-tubulin: 1.00          0.66*
Ratio Bcl-xL/β-tubulin: 1.00      0.90       1.1
Ratio XIAP/β-tubulin: 1.00  0.59* 0.83
β-tubulin  >
c -    >Bcl-2 >
β-tubulin  >
Ratio Bcl-2/β-tubulin: 1.00          0.68*Ratio Bcl-2/β-tubulin: 1.00         0.55*      1.08
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control non-chelated media (C) or chelated media containing 1.5 or
15 lM Zn (for IMR-32 cells) or chelated media containing 1.5 lM
Zn (1.5 Zn) (for rat cortical neurons) for 36 and 24 h, respectively. a
EMSA for NF-jB in nuclear fractions. To determine the specificity of
the NF-jB-DNA complex, the control nuclear fraction (C) was
incubated in the presence of 100-fold molar excess of unlabeled
oligonucleotide containing the consensus sequence for either NF-jB
(C ? NF-jB) or OCT-1 (C ? OCT-1) before the binding assay.
After the EMSA assays, bands were quantitated and values referred to
controls. Results are shown as means ± SEM of three independent
experiments. * Significantly different compared to the C and 15 lM
Zn groups (P \ 0.05, one-way ANOVA test). b The content of
different antiapoptotic proteins was evaluated by Western blot in total
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a critical trigger for the neuronal cell death that occurs
following the induction of Zn deficiency in IMR-32 cells
(Zago et al. 2005). Although treatment with a-lipoic acid
completely prevents the increase in oxidants in IMR-32
cells (Mackenzie et al. 2006b), it did not prevent caspase-3
activation in IMR-32 cells and cortical neurons. This pro-
vides further evidence that oxidative stress does not play a
major role on Zn deficiency-induced neuronal apoptosis.
In this study, we observed a hypophosphorylation of
ERK1/2 and an increased phosphorylation of Akt in asso-
ciation with Zn deficiency in IMR-32 and rat cortical neu-
rons. Concomitantly, the levels of Bad phosphorylated at
Ser-136 were high and no changes in the levels of Bad
phosphorylated at Ser-112 were observed in association with
Zn deficiency in either cell type, compared to controls. The
Bcl-2 family of proteins includes anti-apoptotic and pro-
apoptotic proteins, Bcl-2, and Bcl-X1 mediate cell survival
while Bad and Bax induce cell death. Bad resides in the
cytosol, as an inactive complex with the chaperone 14-3-3
proteins, when it is phosphorylated in at least three serine
residues (Ser-112, 136, and 155) (Zha et al. 1996). These
sites are phosphorylated by different kinases. The phos-
phorylation of Bad at Ser-112 is mediated by ERK (Zhu et al.
2002) and protein kinase A (Yang et al. 2005), Ser-136 is
phosphorylated by Akt (Blume-Jensen et al. 1998), and Ser-
155 by protein kinase A (Virdee et al. 2000). Recent evidence
shows that phosphorylation at the three different sites are
required to prevent Bad translocation to the mitochondria
(Wang et al. 2007). Thus, while Akt can be activated sec-
ondary to Zn deficiency, the inhibition of ERK can drive Bad
translocation, and the subsequent mitochondrial release of
cytochrome c and caspase-3 activation. The activation of
caspase-3 observed in IMR-32 cells and cortical neurons can
also be due to the direct inhibitory action of Zn on the
enzyme. In this regard, caspase-3 is rapidly and directly
activated by Zn chelation in HeLa cells without a require-
ment for an upstream event (Chimienti et al. 2001).
The inhibition of the pro-survival transcription factor
NF-jB could also contribute to Zn deficiency-induced
neuronal apoptosis. The inhibition of NF-jB with the
proteasome inhibitor lactacystin causes apoptosis in IMR-
32 cells (Mackenzie et al. 2002a, 2006a). We previously
described that Zn deficiency alters NF-jB modulation and
inhibits NF-jB-dependent gene expression in IMR-32 cells
(Mackenzie et al. 2002a, 2006a). Consistently, in IMR-32
cells and rat cortical neurons incubated in Zn-deficient
media, we observed a low NF-jB-DNA binding in nuclear
fractions and a decreased expression of the anti-apoptotic
proteins c-IAP1, XIAP, Bcl-xL, and Bcl-2.
In summary, Zn modulates a number of pro-survival
(ERK, Akt, and NF-jB) and pro-apoptotic (JNK and p53)
pathways, and the final consequence of a deficit of Zn will
be the result of the balance between the activation/
inhibition of all of them. In neurons (Fig. 7), a low Zn
availability results in decreased neuronal proliferation, due
to an arrest of the cell cycle in G0/G1 phase, and the trig-
gering of neuronal apoptosis. The inhibition of ERK is an
important player in both processes. Caspase-3 activation,
as a direct consequence of neuronal Zn decrease, is a
central event in the triggering of apoptosis. However,
alterations in cell signals (NF-jB, p53) that regulate the
expression of pro-survival or pro-apoptotic genes can also
contribute to Zn deficiency-induced apoptosis. Given the
relevance of neuronal proliferation and apoptosis in the
developmental shaping of the brain, a suboptimal Zn
nutrition during embryogenesis and early postnatal life can
be a significant risk to the conceptus.
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